Márk Juhász

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

K Gecse, Barbara D. Lovász, Klaudia Farkas et al. · Journal of Crohn s and Colitis · 2015 · 183 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +12

Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centre

Dorottya Kocsis, Zsuzsanna Tóth, Á Csontos et al. · BMC Gastroenterology · 2015 · 55 citations · Full text

Medicine, Immunology, Internal Medicine +17

Efficacy and Safety of Adalimumab in Ulcerative Colitis Refractory to Conventional Therapy in Routine Clinical Practice

Anita Bálint, Klaudia Farkas, Károly Palatka et al. · Journal of Crohn s and Colitis · 2015 · 45 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +16

Coeliac disease in a 15-year period of observation (1997 and 2011) in a Hungarian referral centre

Dorottya Kocsis, Pál Miheller, Katalin Lőrinczy et al. · European Journal of Internal Medicine · 2013 · 17 citations

Medicine, Pathology, Immunopathology +10

Retrospective evaluation of the ten-year experience of a single coeliac centre

Márk Juhász, Dorottya Kocsis, Tamás Zágoni et al. · Orvosi Hetilap · 2012 · 11 citations

Medicine, Internal Medicine, Pathology +15